Association of MGMT-535G>T polymorphism with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy.

被引：0
|
作者：
Chae, Y.
Kim, J.
Sohn, S.
Kang, B.
Ryoo, H.
Bae, S.
Choi, G.
Baek, J.
Kim, Y.
Cho, Y.
机构：
[1] Kyungpook Natl Univ Hosp, Taegu, South Korea
[2] Kyungpook Natl Univ Sch Med, Kyungpook Natl Univ Hosp, Dept Hematol Oncol, Taegu, South Korea
[3] Daegu Catholic Univ Hosp, Taegu, South Korea
[4] Daegu Catholic Univ Coll Med, Dept Internal Med, Div Hematol Oncol, Taegu, South Korea
[5] Ulsan Univ Hosp, Ulsan, South Korea
[6] Dongkuk Univ Hosp, Kyungju, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e14067
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14067
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Angiogenesis gene polymorphisms and clinical outcome of metastatic colorectal cancer treated with first-line bevacizumab and oxaliplatin-based chemotherapy
    Gerger, A.
    Zhang, W.
    Yang, D.
    Bohanes, P. O.
    Ning, Y.
    Winder, T.
    Labonte, M. J.
    Wilson, P. M.
    Benhaim, L.
    El-Khoueiry, R.
    Absenger, G.
    El-Khoueiry, A. B.
    Iqbal, S.
    Lenz, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [42] Neutropenia in colorectal cancer treated with oxaliplatin-based hyperthermic intraperitoneal chemotherapy: An observational cohort study
    Cashin, Peter H.
    Ghanipour, Lana
    Enblad, Malin
    Morris, David L.
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (05) : 549 - 558
  • [43] Handy prognostic model in patients with oxaliplatin-based or irinotecan-based first-line chemotherapy for metastatic colorectal cancer
    Chibaudel, B.
    Tournigand, C.
    Bonnetain, F.
    Andre, T.
    Lledo, G.
    Maindrault-Goebel, F.
    Larsen, A. K.
    Louvet, C.
    de Gramont, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [44] Comparison between three oxaliplatin-based regimens with bevacizumab in patients with metastatic colorectal cancer
    Ohhara, Yoshihito
    Suenaga, Mitsukuni
    Matsusaka, Satoshi
    Shinozaki, Eiji
    Mizunuma, Nobuyuki
    Yamaguchi, Toshiharu
    ONCOTARGETS AND THERAPY, 2015, 8 : 529 - 537
  • [45] Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Advanced Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy
    Kaneko, Manabu
    Nozawa, Hiroaki
    Sasaki, Kazuhito
    Hongo, Kumiko
    Hiyoshi, Masaya
    Tada, Noriko
    Murono, Koji
    Nirei, Takako
    Kawai, Kazushige
    Sunami, Eiji
    Tsuno, Nelson H.
    Kitayama, Joji
    ONCOLOGY, 2012, 82 (05) : 261 - 268
  • [46] USE OF OXALIPLATIN-BASED CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC): A POST-HOC ANALYSIS OF THE GLUTOX STUDY
    Benoit, Samson
    Pierre, Dube
    Nathalie, Aucoin
    Rafal, Wierzbicki
    Jean, Maroun
    Richard, Letourneau
    Eric, Chen
    Danielle, Charpentier
    Felix, Couture
    Mark, Vincent
    Jean, Lepine
    Pierre, Whitlock
    Karine, Alloul
    Francois, Leblond
    Wei, Zhou
    Petr, Kavan
    ANNALS OF ONCOLOGY, 2014, 25
  • [47] Inflammatory cytokines and toxic effects of oxaliplatin-based chemotherapy in patients with colorectal cancer.
    Wang, X. S.
    Cleeland, C. S.
    Johnson, V. E.
    Reuben, J. M.
    Fogelman, D. R.
    Malekifar, M.
    Liao, K. E.
    Liu, P.
    Cohen, E. N.
    Gilmore, K. R.
    Eng, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [48] Pharmacogenetic Angiogenesis Profiling for First-line Bevacizumab plus Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer
    Gerger, Armin
    El-Khoueiry, Anthony
    Zhang, Wu
    Yang, Dongyun
    Singh, Harpreet
    Bohanes, Pierre
    Ning, Yan
    Winder, Thomas
    LaBonte, Melissa J.
    Wilson, Peter M.
    Benhaim, Leonor
    Paez, David
    El-Khoueiry, Rita
    Absenger, Gudrun
    Lenz, Heinz-Josef
    CLINICAL CANCER RESEARCH, 2011, 17 (17) : 5783 - 5792
  • [49] Tandemrepeat variation in HIC1 gene predicts outcome for oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer
    Okazaki, S.
    Loupakis, F.
    Schirripa, M.
    Cao, S.
    Zhang, W.
    Yang, D.
    Ning, Y.
    Berger, M. D.
    Miyamoto, Y.
    Suenaga, M.
    Gopez, R.
    Borelli, B. B.
    Cremolini, C.
    Falcone, A.
    Lonardi, S.
    Salvatore, L.
    Uetake, H.
    Kawano, T.
    Helentjaris, T.
    Lenz, H-J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [50] Impact of Oxaliplatin-based chemotherapy on the haemoglobin levels: A retrospective analysis in patients with colorectal cancer
    Queralt, Bernardo
    Juez, Ignacio
    Hernandez, Xavier
    Vinas, Gemma
    Rubio, Jordi
    Soler, Francesc
    Monleon, Antonio
    Colomer, Ramon
    ANNALS OF ONCOLOGY, 2004, 15 : 86 - 86
12345